Clinical Trial: Use of Propranolol Hydrochloride in the Treatment of Metastatic STS

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional

---

Official Title: The Use of Propranolol Hydrochloride Combined With Anthracyclin Based Chemotherapy in the Treatment of Metastatic Soft Tissue Sarcoma

Brief Summary:

Fifty patients with pathological proof of malignant soft tissue sarcoma will receive Anthracyclin based chemotherapy combined with propranolol 40 mg twice daily.

• The primary end point : To assess Progression Free Survival (PFS)
• The secondary end points : To assess Overall Survival (OS) and Toxicity Profile